Condition: Fistula-in-ano · Sponsor: Signum Surgical USA Inc.
This post market surveillance study is a single arm multicenter study to demonstrate the long-term durability and effectiveness of the BioHealx Anal Fistula Device for fistula-in-ano closure (internal and external fistula openings).
This description comes directly from the study's public registry record.
Katy Feeny · 610-860-6577 · kjclinconsulting@gmail.com
Always discuss trial participation with your own doctor first.
| The Colorectal Institute | Fort Myers, Florida, United States | Recruiting |
| Hackensack University Medical Center | Hackensack, New Jersey, United States | Recruiting |
| Weill Cornell Medicine | New York, New York, United States | Recruiting |
| Northwell Health | Staten Island, New York, United States | Recruiting |
| Maininle Health Lankenau | Bryn Mawr, Pennsylvania, United States | Recruiting |
| Geisinger | Danville, Pennsylvania, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07021742